The recent instability in global supply have highlighted the value of securing essential medications like Ivermectin. Trusting on overseas producers exposes countries to potential vulnerabilities, including transportation delays, expense fluctuations, and even political risks. Moving towards domestic production of Ivermectin offers a multitude of a